Abstract P1-16-02: A randomized phase II study investigating oral metronomic vinorelbine versus conventional dosage of vinorelbine in HER2-negative metastatic breast cancer previously treated with anthracycline or taxane:clinical results and biomarker analysisFei Ma, Binghe Xu, Yanxia Shi et al.|Cancer Research|2022Cited by 0